BB&T Investment Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$497K Sell
6,940
-176
-2% -$13.4K 0.08% 203
2017
Q3
$573K Sell
7,116
-1,906
-21% -$146K 0.11% 160
2017
Q2
$641K Sell
9,022
-692
-7% -$46K 0.16% 126
2017
Q1
$658K Sell
9,714
-2,048
-17% -$144K 0.26% 84
2016
Q4
$845K Buy
+11,762
New +$874K 0.62% 38

Other funds holding GILD

BB&T Investment Services's GILD Position: Q4 2017 in Review

BB&T Investment Services reduced its Gilead Sciences (GILD) stake by 2.5% in Q4 2017, selling an estimated $13.4K and leaving 6,940 shares worth $497K. The position accounts for 0.08% of the portfolio, ranked #203.

BB&T Investment Services first reported a position in GILD in Q4 2016 and has held it in 5 quarters since. The position peaked at $845K in Q4 2016. 1,575 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • BB&T Investment Services held 6,940 shares of Gilead Sciences worth $497K as of Q4 2017.
  • BB&T Investment Services sold 176 Gilead Sciences shares in Q4 2017, an estimated $13.4K.
  • Gilead Sciences made up 0.08% of BB&T Investment Services's portfolio in Q4 2017, its #203 holding.
  • BB&T Investment Services first reported a position in Gilead Sciences in Q4 2016 and has held it in 5 quarters since.
  • BB&T Investment Services's Gilead Sciences position peaked at $845K in Q4 2016.
  • 1,575 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.